WEDNESDAY, April 26, 2023 (HealthDay News) — An extended-release version of a Parkinson’s disease drug could provide more stable relief for patients with the movement disorder, new clinical trial data show. The new formulation of levodopa, called IPX203, extended the duration of patients’ “on time” — the amount of timeContinue Reading

WEDNESDAY, April 26, 2023 (HealthDay News) – The U.S. Food and Drug Administration on Tuesday approved a new drug for people who have a rare, inherited type of amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease. The medication, toferson (Qalsody), targets a mutation in the SOD1-ALS gene. ALSContinue Reading

TUESDAY, April 25, 2023 (HealthDay News) — Each year, about 140 kids in the United States are diagnosed with a craniopharyngioma, a typically non-cancerous brain tumor that develops near the pituitary gland at the base of the brain. Doctors treat craniopharyngiomas with surgery to remove the entire tumor or aContinue Reading